Nav: Home

Phobic anxiety is linked to sexuality issues in women who are breast cancer survivors

November 05, 2018

A study carried out by a research team made up of researchers from the University of Cordoba, the Maimonides Institute of Biomedical Research (in Spanish abbreviated to IMIBIC) and Queen Sofia University Hospital revealed that sexual dysfunction suffered by women who are breast cancer survivors is linked to phobic anxiety, which nevertheless, does not affect sexual function in women with no history of cancer.

For women who have survived breast cancer, this type of anxiety can result in sexual intercourse being an unpleasant experience. These women have difficulty with excitement, lubrication, orgasms and with experiencing intercourse as a satisfying and pleasant experience.

Though there are other factors that affect sexual dysfunction in women who have undergone cancer treatment, this recently published study in the journal Psycho-Oncology points out that psychological impact can be enough to cause a problem in a woman's sexual behavior and that women can lose desire to have intercourse and try to avoid having intercourse.

University of Cordoba researcher, Ana Abril Requena, explains that "phobic anxiety is consistently linked to sexual changes in this group of patients, which proves the significance of psychosocial factors upon sexuality, causing sexual relations to be unpleasant experiences in these cases." Though it is true that certain kinds of cancer affect sexuality more than others, such as those affecting reproductive organs, this research reveals that, in the case of breast cancer, phobic anxiety is the main reason that leads to a lack of sexual drive. In this group of patients, les sexual activity and less interest in sex was observed, as well as a worse perception of one's attractiveness and femininity.

Abril points out that the discoveries made in the research "can be used to help prevent these kinds of issues and to develop more specific responses to help reduce the symptoms that negatively affect the quality of life for patients and their partners by means of, for instance, behavioral therapy and relaxation techniques."

From this study, another interesting piece of information has been shown related to women cancer survivors but not consisting in symptoms or side effects. This is that most female breast cancer survivors "are not satisfied with the quantity nor quality of the information provided to them by healthcare providers regarding breast cancer's side effects on their sexuality after being diagnosed and above all after receiving treatment. The research shows that 79.3% of the women studied professed this opinion.

This research project was carried out by means of questionnaires administered to two groups of women: one was made up of women who had been diagnosed with cancer and had finished treatment and the other was made up of women with no cancer history. Each group consisted of 30 people with an average age of 55. Most of the participants were married and there was a similar educational level in the two groups. Within the group of patients, most had undergone chemotherapy (76.7%) and/or radiation therapy (73.3%), followed by hormone therapy (60%; 23.3%) and breast-conserving surgery (50%).

This method allows for measuring different dimensions of anxiety with standardized questionnaires such as the Inventory of Situations and Responses of Anxiety (abbreviated to ISRA-B in Spanish) and the Female Sexual Function Index (FSFI). The former obtains information on the three systems of anxiety (cognitive, physiological and motor) and on four specific characteristics of anxiety (in assessment, interpersonal, phobic and daily life situations). The latter, FSFI, assesses six different domains: desire, excitement, lubrication, orgasms, satisfaction and pain.
Abril?Requena A, García?Torres F, Alós FJ. Sexual dysfunction and phobic anxiety in breast cancer survivors. Psycho-Oncology. 2018; 1-3.

University of Córdoba

Related Breast Cancer Articles:

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.
Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.
Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.
More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.
Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.
Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.
Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.
Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.
Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.
Does MRI plus mammography improve detection of new breast cancer after breast conservation therapy?
A new article published by JAMA Oncology compares outcomes for combined mammography and MRI or ultrasonography screenings for new breast cancers in women who have previously undergone breast conservation surgery and radiotherapy for breast cancer initially diagnosed at 50 or younger.
More Breast Cancer News and Breast Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at